BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19502098)

  • 1. The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas.
    Wiegand S; Dakic B; Rath AF; Makarova G; Sterz C; Meissner W; Bette M; Adamkiewicz J; Müller-Brüsselbach S; Müller R; Werner JA; Mandic R
    Oral Oncol; 2009 Oct; 45(10):e140-9. PubMed ID: 19502098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
    Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
    Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells.
    Zhou L; Park BH; Park JH; Jang KY; Park HS; Wagle S; Lee KB; Kim JR
    Oncol Rep; 2013 Jan; 29(1):193-8. PubMed ID: 23129219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
    Mathur R; Chandna S; N Kapoor P; S Dwarakanath B
    Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
    Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T
    PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
    Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
    Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIN1 inhibition suppresses osteoclast differentiation and inflammatory responses.
    Cho YA; Jue SS; Bae WJ; Heo SH; Shin SI; Kwon IK; Lee SC; Kim EC
    J Dent Res; 2015 Feb; 94(2):371-80. PubMed ID: 25512367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of low and high doses of Taxol in anaplastic thyroid cancer cells: possible implication of the Pin1 prolyl isomerase.
    Pushkarev VM; Starenki DV; Saenko VA; Pushkarev VV; Kovzun OI; Tronko MD; Popadiuk ID; Yamashita S
    Exp Oncol; 2008 Sep; 30(3):190-4. PubMed ID: 18806740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Plk1 and Pin1 by 5'-nitro-indirubinoxime suppresses human lung cancer cells.
    Yoon HE; Kim SA; Choi HS; Ahn MY; Yoon JH; Ahn SG
    Cancer Lett; 2012 Mar; 316(1):97-104. PubMed ID: 22115795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription.
    Chao SH; Greenleaf AL; Price DH
    Nucleic Acids Res; 2001 Feb; 29(3):767-73. PubMed ID: 11160900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.
    Ryo A; Hirai A; Nishi M; Liou YC; Perrem K; Lin SC; Hirano H; Lee SW; Aoki I
    J Biol Chem; 2007 Dec; 282(50):36671-81. PubMed ID: 17938171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-dependent induction of BCL-xL and p21CIP1/WAF1 is highly variable in HNSCC cells--implications for EGFR-targeted therapies.
    Rüddel J; Wennekes VE; Meissner W; Werner JA; Mandic R
    Anticancer Res; 2010 Nov; 30(11):4579-85. PubMed ID: 21115909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression.
    Li H; Wang S; Zhu T; Zhou J; Xu Q; Lu Y; Ma D
    Oncol Rep; 2006 Sep; 16(3):491-6. PubMed ID: 16865248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.
    Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L
    Tumori; 2016; 102(2):144-9. PubMed ID: 26917410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy regulated by prolyl isomerase Pin1 and phospho-Ser-GSK3αβ involved in protection of oral squamous cell carcinoma against cadmium toxicity.
    So KY; Ahn SG; Oh SH
    Biochem Biophys Res Commun; 2015 Oct; 466(3):541-6. PubMed ID: 26381174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisite phosphorylation of Pin1-associated mitotic phosphoproteins revealed by monoclonal antibodies MPM-2 and CC-3.
    Albert AL; Lavoie SB; Vincent M
    BMC Cell Biol; 2004 Jun; 5():22. PubMed ID: 15171797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.